- Home
- TALKW vs CADL Comparison
TALKW vs CADL Comparison
Compare TALKW & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TALKW | CADL |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | 521 | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 339.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | TALKW | CADL |
|---|---|---|
| Price | $0.05 | $6.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $19.43 |
| AVG Volume (30 Days) | 64.2K | ★ 936.0K |
| Earning Date | 02-20-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $181,291,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.20 | $4.25 |
| 52 Week High | $0.24 | $13.68 |
Technical Indicators
Market Signals| Indicator | TALKW | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 51.49 | 72.12 |
| Support Level | $0.04 | $5.39 |
| Resistance Level | $0.05 | $6.83 |
| Average True Range (ATR) | 0.01 | 0.36 |
| MACD | 0.00 | 0.22 |
| Stochastic Oscillator | 43.00 | 80.81 |
Price Performance
Historical ComparisonAbout TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.